RNAi Roundtable: ALN-AT3 for the treatment of Hemophilia and Rare Bleeding Disorders

RNAi Roundtable: ALN-AT3 for the treatment of Hemophilia and Rare Bleeding Disorders

On July 22, 2015, we hosted an online RNAi Roundtable to review the progress with ALN-AT3 in development for the treatment of Hemophilia and Rare Bleeding Disorders.

View the presentation
Read the transcript



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.